Will TNX-102 SL Receive FDA Approval for the Treatment of Fibromyalgia?
Basic
1
Ṁ152026
57%
chance
1D
1W
1M
ALL
This market predicts whether the FDA will approve TNX-102 SL for treating fibromyalgia. The FDA has accepted the NDA and given Fast Track designation. Resolution will be based on official FDA announcements and Tonix press releases.
References:
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Related questions
Related questions
Pain Relief vs Addiction: Will Vertex’s non-opioid (hopefully nonaddictive) Suzetrigine/VX-548 be FDA-approved in 2024?
31% chance
Will AOH1996 be FDA approved before 2040?
44% chance
Will there be an FDA Approved treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by 2030.
35% chance
Will the FDA approve a drug to prevent migraine headaches by 2025?
66% chance
Zuranolone gets FDA approval for some other condition
48% chance
Will the FDA approve MDMA as a treatment for PTSD by the end of 2024?
3% chance
Zuranolone gets FDA approval for major depression
43% chance
[Metaculus] Will MDMA be FDA-approved for the treatment of PTSD before 2025?
1% chance
When will the "100% effective against solid tumors" cancer pill AOH1996 be approved by the FDA?
Will FDA approve any mRNA vaccine against Lyme disease before 2028?
27% chance